Back to Rankings

ENVB

Enveric BiosciencesB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
ENVB vs peer average
88/100
ENVB vs. peer average (B vs. D)
Grade spread
A 1 · D 3 · F 7
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

ARTL is the first available peer comparator.

Artelo is another micro-cap clinical-stage biotech where valuation is heavily driven by financing capacity and development milestones rather than current revenue, making it a reasonable volatility comp.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerARTLArtelo Biosciences
ENVB
Enveric Biosciences
ARTL
Artelo Biosciences
Grade
B
F
Momentum
97
1
Value
41
41
Sentiment
31
57
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs ARTL

ENVB / ARTL
Grade Position
Above peers
ENVB vs. peer average (B vs. D)
88/100
Momentum
97
ENVB
Value
41
ENVB
Sentiment
31
ARTL

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ENVB
1
ARTL
ARTL
F
20/100
+3
2
DRMA
DRMA
D
40/100
+2
3
ONCO
ONCO
F
20/100
+3
4
CELZ
Creative Medical Technology Holdings Inc Common
F
20/100
+3
5
ACXP
Acurx Pharmaceuticals Inc Common
F
20/100
+3
ARTL is the first peer returned for this comparison set.